 REDWOOD CITY, CA ACCESSWIRE May 6, 2020 Avinger, Inc. AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease PAD, today announced that the underwriters of its previously announced underwritten public offering have exercised in full their option to purchase an additional 1,890,000 shares of its common stock at a price of 0.25 per share. The shares were offered pursuant to a registration statement on Form S-1 previously filed with and declared effective by the Securities and Exchange Commission SEC. A final prospectus relating to the offering was filed with the SEC and is available on the SECs website at 